Goal Guide · 2026

Best Peptides for Anxiety and Mood

Summary

The best-researched peptides for anxiety and mood are Oxytocin (Grade A), N-Acetyl Selank Amidate (Grade B), and N-Acetyl Semax Amidate (Grade B). Oxytocin is supported by the strongest clinical evidence for reducing stress response and improving emotional regulation. Selank demonstrates consistent anxiolytic and mood-stabilizing effects in controlled studies. Semax contributes indirectly through enhanced cognitive processing and attentional control, which are closely linked to anxiety management.

Understanding Anxiety and Mood with Peptides

Peptides address anxiety and mood dysregulation through several intersecting biological pathways. Neuropeptides such as oxytocin bind to receptors in the amygdala and hypothalamus, directly modulating fear response, stress hormone release, and social reward circuitry. Nootropic peptides like Selank interact with the GABAergic system and influence serotonin metabolism, producing anxiolytic effects without the sedation associated with traditional benzodiazepines. This receptor-level specificity is one reason peptide-based approaches have attracted growing interest in psychiatric research.

Two peptide classes are particularly relevant to anxiety and mood outcomes. The first is neuropeptide hormones, represented here by oxytocin and kisspeptin-10, which modulate the hypothalamic-pituitary axis and influence neurochemical states tied to social behavior, trust, and hormonal balance. The second class is synthetic regulatory peptides, including the Semax and Selank variants, which were originally developed in Soviet-era neuropharmacology programs and have since been studied for their BDNF-modulating, neuroprotective, and anxiolytic properties. NSI-189, while technically a small-molecule aminopyridine, is often grouped with peptide research due to its hippocampal neurogenesis profile and relevance to depressive disorders.

The evidence base for peptides in anxiety and mood is heterogeneous but growing. Oxytocin holds Grade A status, supported by multiple randomized controlled trials demonstrating measurable reductions in cortisol response and improvements in emotional recognition. Selank and Semax carry Grade B designations, meaning their support derives primarily from controlled preclinical studies and smaller human trials, many conducted in Russian clinical settings. NSI-189 has completed Phase 1 and Phase 2a trials with signals for antidepressant effect, though Phase 2b results were more modest. Kisspeptin-10 evidence is more concentrated in reproductive endocrinology, with mood effects considered secondary to testosterone normalization.

Peptides Ranked by Evidence (21 found)

Peptide	Evidence	Primary Mechanism
Oxytocin	AEvidenceGrade ALarge human randomised controlled trials or FDA/major-authority approved	Reduces anxiety and stress response	Research →
Kisspeptin-10	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Mood enhancement	Research →
N-Acetyl Selank Amidate	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Reduces anxiety and promotes relaxation	Research →
N-Acetyl Semax Amidate	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Enhances mood and motivation	Research →
NA-Semax-Amidate	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Reduces anxiety and stress response	Research →
NSI-189	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	May improve mood and depression symptoms	Research →
SS-31	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Reduces oxidative stress in cells	Research →
Selank	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Reduces anxiety and stress responses	Research →
Semax	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Increases stress resilience and anxiety reduction	Research →
Tesofensine	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Improves mood and motivation	Research →
Thymalin	BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries	Improves stress resistance	Research →
Cortagen	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	May improve mood and emotional regulation	Research →
DSIP	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	Reduces stress	Research →
Ipamorelin	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	Minimal effect on cortisol and prolactin	Research →
MGF	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	Supports recovery from mechanical stress	Research →
Thymagen	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	May improve recovery from immune stress	Research →
Vilon	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	May normalize cortisol	Research →
Enkephalins (Met-Enkephalin, Leu-Enkephalin)		Influences mood and emotional regulation	Research →
Humanin	DEvidenceGrade DTheoretical or in-vitro only; no meaningful independent human evidence	Protects neurons from apoptosis and oxidative stress	Research →
Neuropeptide Y (NPY)		Reduces anxiety and stress response	Research →
P21	DEvidenceGrade DTheoretical or in-vitro only; no meaningful independent human evidence	Potential depression treatment	Research →

Top Picks by Evidence Grade

Oxytocin

AEvidenceGrade ALarge human randomised controlled trials or FDA/major-authority approved

Reduces anxiety and stress response

View research page →

Kisspeptin-10

BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries

Mood enhancement

View research page →

N-Acetyl Selank Amidate

BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries

Reduces anxiety and promotes relaxation

View research page →

N-Acetyl Semax Amidate

BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries

Enhances mood and motivation

View research page →

Getting Started

Identify your primary symptom target

Research suggests distinguishing between generalized anxiety, social anxiety, and mood dysregulation matters when reviewing peptide options. Oxytocin research is strongest for social and stress-related anxiety, while Selank data concentrates on generalized anxiolytic effects.

Review evidence grade and delivery route

Each peptide in this category differs in bioavailability and administration method. Intranasal delivery is common for oxytocin and Semax variants, while Selank is also studied in intranasal form. Understanding these routes is essential context before reviewing any research protocol.

Consult a qualified medical professional

Peptide research in psychiatric applications involves nuanced interactions with existing neurochemistry and medications. Engaging a physician or psychiatrist familiar with peptide literature is the appropriate first step before any personal consideration of these compounds.

Related Side-by-Side Comparisons

Detailed evidence comparisons for the top anxiety and mood peptides.

selank vs semax

Compare →

Frequently Asked Questions

How do anxiety-targeting peptides differ from conventional anxiolytic medications?⌄

Unlike benzodiazepines or SSRIs, which broadly suppress CNS activity or alter systemic serotonin reuptake, many anxiety-related peptides act on more specific receptor populations or signaling pathways. Selank, for example, has been studied for GABA modulation without producing the dependence or cognitive blunting associated with classical anxiolytics. However, this specificity also means the clinical evidence base is less mature compared to established pharmaceutical options.

Can peptides address both anxiety and mood simultaneously, or do they target one more than the other?⌄

Several peptides in this category show overlapping activity across both domains. N-Acetyl Selank Amidate research documents both anxiolytic and mood-stabilizing outcomes, attributed partly to its influence on serotonin and BDNF expression. Oxytocin similarly affects stress reactivity and emotional tone together. The distinction is not always clean in the literature because anxiety and mood dysregulation share significant neurobiological overlap.

Is there a risk of dependency or tolerance with peptides used for anxiety?⌄

Current research on Selank and Semax variants does not indicate classic dependency profiles, and they are not scheduled substances in most jurisdictions. That said, long-term human safety data is limited compared to approved anxiolytics. Oxytocin use over extended periods has raised questions in some studies about receptor downregulation and altered baseline social behavior, which underscores the need for professional oversight.

How does hippocampal neurogenesis relate to mood disorders, and where does NSI-189 fit?⌄

The hippocampal neurogenesis hypothesis of depression posits that reduced new neuron formation in the hippocampus contributes to depressive symptoms, and that effective antidepressants partly work by restoring this process. NSI-189 was designed specifically to stimulate hippocampal neurogenesis and has shown increases in hippocampal volume in early trials. While its Phase 2b primary endpoint was not met, secondary mood outcome measures showed encouraging signals that continue to be studied.

Not sure where to start?

The Goal Finder asks 3 questions and gives you a personalised peptide recommendation ranked by evidence grade.

Use Goal Finder →Compare Peptides

Explore Other Goals

Fat Loss Better Sleep Recovery and Healing Muscle Growth Cognitive Performance Longevity and Anti-Aging Sexual Health Skin Health Immune Support